Pinnacle Financial Partners (Tennessee)’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-730
Closed -$48.2K – 526
2024
Q4
$48.2K Hold
730
– – ﹤0.01% 482
2024
Q3
$48.2K Sell
730
-800
-52% -$58.1K ﹤0.01% 481
2024
Q2
$146K Sell
1,530
-2,510
-62% -$222K ﹤0.01% 444
2024
Q1
$386K Buy
4,040
+2,510
+164% +$211K 0.01% 346
2023
Q4
$117K Hold
1,530
– – ﹤0.01% 425
2023
Q3
$106K Sell
1,530
-2,563
-63% -$206K ﹤0.01% 405
2023
Q2
$386K Buy
4,093
+2,563
+168% +$223K 0.01% 322
2023
Q1
$127K Hold
1,530
– – ﹤0.01% 396
2022
Q4
$114K Hold
1,530
– – ﹤0.01% 388
2022
Q3
$126K Buy
+1,530
New +$147K ﹤0.01% 368
2022
Q2
– Sell
-435
Closed -$51K – 439
2022
Q1
$51K Hold
435
– – ﹤0.01% 384
2021
Q4
$56K Sell
435
-220
-34% -$25.7K ﹤0.01% 411
2021
Q3
$74K Buy
655
+220
+51% +$25.1K ﹤0.01% 390
2021
Q2
$45K Buy
+435
New +$41K ﹤0.01% 397
2019
Q1
– Sell
-4,137
Closed -$211K – 456
2018
Q4
$211K Sell
4,137
-1,122
-21% -$56.8K 0.02% 305
2018
Q3
$305K Buy
5,259
+3,759
+251% +$184K 0.03% 275
2018
Q2
$73K Buy
+1,500
New +$70K 0.01% 328
2017
Q3
– Sell
-1,050
Closed -$41K – 329
2017
Q2
$41K Buy
+1,050
New +$38.3K 0.01% 355

Other funds holding EW

Pinnacle Financial Partners (Tennessee)'s EW Position: Q1 2025 in Review

Pinnacle Financial Partners (Tennessee) sold out of Edwards Lifesciences (EW) in Q1 2025, closing a stake of 730 shares — an estimated $48.2K sold.

Pinnacle Financial Partners (Tennessee) first reported a position in EW in Q2 2017 and held it in 18 quarters. The position peaked at $386K in Q2 2023. 1,207 funds tracked by Wall St. Rank hold EW as of Q1 2025.

  • Pinnacle Financial Partners (Tennessee) reported no remaining Edwards Lifesciences position as of Q1 2025 after selling out during the quarter.
  • Pinnacle Financial Partners (Tennessee) sold 730 Edwards Lifesciences shares in Q1 2025, an estimated $48.2K.
  • Pinnacle Financial Partners (Tennessee) first reported a position in Edwards Lifesciences in Q2 2017 and held it in 18 quarters.
  • Pinnacle Financial Partners (Tennessee)'s Edwards Lifesciences position peaked at $386K in Q2 2023.
  • 1,207 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2025.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q1 2025, filed 28 Apr 2025.